Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.

A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.

The global Biosimilar Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

In China, Biosimilar Drug key players include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, etc. Global top three manufacturers hold a share over 70%.

East China is the largest market, with a share over 70%, followed by North China, with a share about 15 percent.

In terms of product, Tablets is the largest segment, with a share over 65%. And in terms of application, the largest application is Ankylosing Spondylitis, followed by Rheumatoid Arthrtis, Tumor, Cardiovascular, etc.

This report aims to provide a comprehensive presentation of the global market for Biosimilar Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilar Drug.

Report Scope

The Biosimilar Drug market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biosimilar Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biosimilar Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biosimilar Drug Market Report

Report Metric	Details
Report Name	Biosimilar Drug Market
Segment by Type	Injection Tablets Other Types
Segment by Application	Ankylosing Spondylitis Tumor Rheumatoid Arthrtis Cardiovascular Other Application
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	CP Guojian Pharma, Biotech Pharma, Celgen Pharma, Henlius, Amgen, Eli Lilly, Sandoz, Changchun High Tech, Innovent
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biosimilar Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biosimilar Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

What is the market share of major companies in Biosimilar Drug Market?

Ans: Global top three manufacturers hold a share over 70%.

What is the Biosimilar Drug Market share by region?

Ans: East China is the largest market, with a share over 70%, followed by North China, with a share about 15 percent.

What is the Biosimilar Drug Market share by type?

Ans: In terms of product, Tablets is the largest segment, with a share over 65%.

Who are the main players in the Biosimilar Drug Market report?

Ans: The main players in the Biosimilar Drug Market are CP Guojian Pharma, Biotech Pharma, Celgen Pharma, Henlius, Amgen, Eli Lilly, Sandoz, Changchun High Tech, Innovent

What are the Application segmentation covered in the Biosimilar Drug Market report?

Ans: The Applications covered in the Biosimilar Drug Market report are Ankylosing Spondylitis, Tumor, Rheumatoid Arthrtis, Cardiovascular, Other Application

What are the Type segmentation covered in the Biosimilar Drug Market report?

Ans: The Types covered in the Biosimilar Drug Market report are Injection, Tablets, Other Types

1 Biosimilar Drug Market Overview

1.1 Product Overview and Scope of Biosimilar Drug

1.2 Biosimilar Drug Segment by Type

1.2.1 Global Biosimilar Drug Market Value Comparison by Type (2024-2030)

1.2.2 Injection

1.2.3 Tablets

1.2.4 Other Types

1.3 Biosimilar Drug Segment by Application

1.3.1 Global Biosimilar Drug Market Value by Application: (2024-2030)

1.3.2 Ankylosing Spondylitis

1.3.3 Tumor

1.3.4 Rheumatoid Arthrtis

1.3.5 Cardiovascular

1.3.6 Other Application

1.4 Global Biosimilar Drug Market Size Estimates and Forecasts

1.4.1 Global Biosimilar Drug Revenue 2019-2030

1.4.2 Global Biosimilar Drug Sales 2019-2030

1.4.3 Global Biosimilar Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Biosimilar Drug Market Competition by Manufacturers

2.1 Global Biosimilar Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global Biosimilar Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Biosimilar Drug Average Price by Manufacturers (2019-2024)

2.4 Global Biosimilar Drug Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Biosimilar Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Biosimilar Drug, Product Type & Application

2.7 Biosimilar Drug Market Competitive Situation and Trends

2.7.1 Biosimilar Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Biosimilar Drug Players Market Share by Revenue

2.7.3 Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Biosimilar Drug Retrospective Market Scenario by Region

3.1 Global Biosimilar Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Biosimilar Drug Global Biosimilar Drug Sales by Region: 2019-2030

3.2.1 Global Biosimilar Drug Sales by Region: 2019-2024

3.2.2 Global Biosimilar Drug Sales by Region: 2025-2030

3.3 Global Biosimilar Drug Global Biosimilar Drug Revenue by Region: 2019-2030

3.3.1 Global Biosimilar Drug Revenue by Region: 2019-2024

3.3.2 Global Biosimilar Drug Revenue by Region: 2025-2030

3.4 North America Biosimilar Drug Market Facts & Figures by Country

3.4.1 North America Biosimilar Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Biosimilar Drug Sales by Country (2019-2030)

3.4.3 North America Biosimilar Drug Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Biosimilar Drug Market Facts & Figures by Country

3.5.1 Europe Biosimilar Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Biosimilar Drug Sales by Country (2019-2030)

3.5.3 Europe Biosimilar Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Biosimilar Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Biosimilar Drug Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Biosimilar Drug Sales by Country (2019-2030)

3.6.3 Asia Pacific Biosimilar Drug Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Biosimilar Drug Market Facts & Figures by Country

3.7.1 Latin America Biosimilar Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Biosimilar Drug Sales by Country (2019-2030)

3.7.3 Latin America Biosimilar Drug Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Biosimilar Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Biosimilar Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Biosimilar Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa Biosimilar Drug Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Biosimilar Drug Sales by Type (2019-2030)

4.1.1 Global Biosimilar Drug Sales by Type (2019-2024)

4.1.2 Global Biosimilar Drug Sales by Type (2025-2030)

4.1.3 Global Biosimilar Drug Sales Market Share by Type (2019-2030)

4.2 Global Biosimilar Drug Revenue by Type (2019-2030)

4.2.1 Global Biosimilar Drug Revenue by Type (2019-2024)

4.2.2 Global Biosimilar Drug Revenue by Type (2025-2030)

4.2.3 Global Biosimilar Drug Revenue Market Share by Type (2019-2030)

4.3 Global Biosimilar Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global Biosimilar Drug Sales by Application (2019-2030)

5.1.1 Global Biosimilar Drug Sales by Application (2019-2024)

5.1.2 Global Biosimilar Drug Sales by Application (2025-2030)

5.1.3 Global Biosimilar Drug Sales Market Share by Application (2019-2030)

5.2 Global Biosimilar Drug Revenue by Application (2019-2030)

5.2.1 Global Biosimilar Drug Revenue by Application (2019-2024)

5.2.2 Global Biosimilar Drug Revenue by Application (2025-2030)

5.2.3 Global Biosimilar Drug Revenue Market Share by Application (2019-2030)

5.3 Global Biosimilar Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 CP Guojian Pharma

6.1.1 CP Guojian Pharma Corporation Information

6.1.2 CP Guojian Pharma Description and Business Overview

6.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 CP Guojian Pharma Biosimilar Drug Product Portfolio

6.1.5 CP Guojian Pharma Recent Developments/Updates

6.2 Biotech Pharma

6.2.1 Biotech Pharma Corporation Information

6.2.2 Biotech Pharma Description and Business Overview

6.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Biotech Pharma Biosimilar Drug Product Portfolio

6.2.5 Biotech Pharma Recent Developments/Updates

6.3 Celgen Pharma

6.3.1 Celgen Pharma Corporation Information

6.3.2 Celgen Pharma Description and Business Overview

6.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Celgen Pharma Biosimilar Drug Product Portfolio

6.3.5 Celgen Pharma Recent Developments/Updates

6.4 Henlius

6.4.1 Henlius Corporation Information

6.4.2 Henlius Description and Business Overview

6.4.3 Henlius Biosimilar Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Henlius Biosimilar Drug Product Portfolio

6.4.5 Henlius Recent Developments/Updates

6.5 Amgen

6.5.1 Amgen Corporation Information

6.5.2 Amgen Description and Business Overview

6.5.3 Amgen Biosimilar Drug Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Amgen Biosimilar Drug Product Portfolio

6.5.5 Amgen Recent Developments/Updates

6.6 Eli Lilly

6.6.1 Eli Lilly Corporation Information

6.6.2 Eli Lilly Description and Business Overview

6.6.3 Eli Lilly Biosimilar Drug Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Eli Lilly Biosimilar Drug Product Portfolio

6.6.5 Eli Lilly Recent Developments/Updates

6.7 Sandoz

6.6.1 Sandoz Corporation Information

6.6.2 Sandoz Description and Business Overview

6.6.3 Sandoz Biosimilar Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sandoz Biosimilar Drug Product Portfolio

6.7.5 Sandoz Recent Developments/Updates

6.8 Changchun High Tech

6.8.1 Changchun High Tech Corporation Information

6.8.2 Changchun High Tech Description and Business Overview

6.8.3 Changchun High Tech Biosimilar Drug Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Changchun High Tech Biosimilar Drug Product Portfolio

6.8.5 Changchun High Tech Recent Developments/Updates

6.9 Innovent

6.9.1 Innovent Corporation Information

6.9.2 Innovent Description and Business Overview

6.9.3 Innovent Biosimilar Drug Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Innovent Biosimilar Drug Product Portfolio

6.9.5 Innovent Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Biosimilar Drug Industry Chain Analysis

7.2 Biosimilar Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Biosimilar Drug Production Mode & Process

7.4 Biosimilar Drug Sales and Marketing

7.4.1 Biosimilar Drug Sales Channels

7.4.2 Biosimilar Drug Distributors

7.5 Biosimilar Drug Customers

8 Biosimilar Drug Market Dynamics

8.1 Biosimilar Drug Industry Trends

8.2 Biosimilar Drug Market Drivers

8.3 Biosimilar Drug Market Challenges

8.4 Biosimilar Drug Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Biosimilar Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Biosimilar Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Biosimilar Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global Biosimilar Drug Sales (K Dose) of Key Manufacturers (2019-2024)

Table 5. Global Biosimilar Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Biosimilar Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Biosimilar Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Biosimilar Drug Average Price (USD/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Biosimilar Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Biosimilar Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Biosimilar Drug, Product Type & Application

Table 12. Global Key Manufacturers of Biosimilar Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Biosimilar Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Biosimilar Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Biosimilar Drug Sales by Region (2019-2024) & (K Dose)

Table 18. Global Biosimilar Drug Sales Market Share by Region (2019-2024)

Table 19. Global Biosimilar Drug Sales by Region (2025-2030) & (K Dose)

Table 20. Global Biosimilar Drug Sales Market Share by Region (2025-2030)

Table 21. Global Biosimilar Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Biosimilar Drug Revenue Market Share by Region (2019-2024)

Table 23. Global Biosimilar Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Biosimilar Drug Revenue Market Share by Region (2025-2030)

Table 25. North America Biosimilar Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Biosimilar Drug Sales by Country (2019-2024) & (K Dose)

Table 27. North America Biosimilar Drug Sales by Country (2025-2030) & (K Dose)

Table 28. North America Biosimilar Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Biosimilar Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Biosimilar Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Biosimilar Drug Sales by Country (2019-2024) & (K Dose)

Table 32. Europe Biosimilar Drug Sales by Country (2025-2030) & (K Dose)

Table 33. Europe Biosimilar Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Biosimilar Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Biosimilar Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Biosimilar Drug Sales by Region (2019-2024) & (K Dose)

Table 37. Asia Pacific Biosimilar Drug Sales by Region (2025-2030) & (K Dose)

Table 38. Asia Pacific Biosimilar Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Biosimilar Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Biosimilar Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Biosimilar Drug Sales by Country (2019-2024) & (K Dose)

Table 42. Latin America Biosimilar Drug Sales by Country (2025-2030) & (K Dose)

Table 43. Latin America Biosimilar Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Biosimilar Drug Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Biosimilar Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Biosimilar Drug Sales by Country (2019-2024) & (K Dose)

Table 47. Middle East & Africa Biosimilar Drug Sales by Country (2025-2030) & (K Dose)

Table 48. Middle East & Africa Biosimilar Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Biosimilar Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Biosimilar Drug Sales (K Dose) by Type (2019-2024)

Table 51. Global Biosimilar Drug Sales (K Dose) by Type (2025-2030)

Table 52. Global Biosimilar Drug Sales Market Share by Type (2019-2024)

Table 53. Global Biosimilar Drug Sales Market Share by Type (2025-2030)

Table 54. Global Biosimilar Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Biosimilar Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Biosimilar Drug Revenue Market Share by Type (2019-2024)

Table 57. Global Biosimilar Drug Revenue Market Share by Type (2025-2030)

Table 58. Global Biosimilar Drug Price (USD/Dose) by Type (2019-2024)

Table 59. Global Biosimilar Drug Price (USD/Dose) by Type (2025-2030)

Table 60. Global Biosimilar Drug Sales (K Dose) by Application (2019-2024)

Table 61. Global Biosimilar Drug Sales (K Dose) by Application (2025-2030)

Table 62. Global Biosimilar Drug Sales Market Share by Application (2019-2024)

Table 63. Global Biosimilar Drug Sales Market Share by Application (2025-2030)

Table 64. Global Biosimilar Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Biosimilar Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Biosimilar Drug Revenue Market Share by Application (2019-2024)

Table 67. Global Biosimilar Drug Revenue Market Share by Application (2025-2030)

Table 68. Global Biosimilar Drug Price (USD/Dose) by Application (2019-2024)

Table 69. Global Biosimilar Drug Price (USD/Dose) by Application (2025-2030)

Table 70. CP Guojian Pharma Corporation Information

Table 71. CP Guojian Pharma Description and Business Overview

Table 72. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 73. CP Guojian Pharma Biosimilar Drug Product

Table 74. CP Guojian Pharma Recent Developments/Updates

Table 75. Biotech Pharma Corporation Information

Table 76. Biotech Pharma Description and Business Overview

Table 77. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 78. Biotech Pharma Biosimilar Drug Product

Table 79. Biotech Pharma Recent Developments/Updates

Table 80. Celgen Pharma Corporation Information

Table 81. Celgen Pharma Description and Business Overview

Table 82. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 83. Celgen Pharma Biosimilar Drug Product

Table 84. Celgen Pharma Recent Developments/Updates

Table 85. Henlius Corporation Information

Table 86. Henlius Description and Business Overview

Table 87. Henlius Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 88. Henlius Biosimilar Drug Product

Table 89. Henlius Recent Developments/Updates

Table 90. Amgen Corporation Information

Table 91. Amgen Description and Business Overview

Table 92. Amgen Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 93. Amgen Biosimilar Drug Product

Table 94. Amgen Recent Developments/Updates

Table 95. Eli Lilly Corporation Information

Table 96. Eli Lilly Description and Business Overview

Table 97. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 98. Eli Lilly Biosimilar Drug Product

Table 99. Eli Lilly Recent Developments/Updates

Table 100. Sandoz Corporation Information

Table 101. Sandoz Description and Business Overview

Table 102. Sandoz Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 103. Sandoz Biosimilar Drug Product

Table 104. Sandoz Recent Developments/Updates

Table 105. Changchun High Tech Corporation Information

Table 106. Changchun High Tech Description and Business Overview

Table 107. Changchun High Tech Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 108. Changchun High Tech Biosimilar Drug Product

Table 109. Changchun High Tech Recent Developments/Updates

Table 110. Innovent Corporation Information

Table 111. Innovent Description and Business Overview

Table 112. Innovent Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 113. Innovent Biosimilar Drug Product

Table 114. Innovent Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Biosimilar Drug Distributors List

Table 118. Biosimilar Drug Customers List

Table 119. Biosimilar Drug Market Trends

Table 120. Biosimilar Drug Market Drivers

Table 121. Biosimilar Drug Market Challenges

Table 122. Biosimilar Drug Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Biosimilar Drug

Figure 2. Global Biosimilar Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Biosimilar Drug Market Share by Type in 2023 & 2030

Figure 4. Injection Product Picture

Figure 5. Tablets Product Picture

Figure 6. Other Types Product Picture

Figure 7. Global Biosimilar Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Biosimilar Drug Market Share by Application in 2023 & 2030

Figure 9. Ankylosing Spondylitis

Figure 10. Tumor

Figure 11. Rheumatoid Arthrtis

Figure 12. Cardiovascular

Figure 13. Other Application

Figure 14. Global Biosimilar Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Biosimilar Drug Market Size (2019-2030) & (US$ Million)

Figure 16. Global Biosimilar Drug Sales (2019-2030) & (K Dose)

Figure 17. Global Biosimilar Drug Average Price (USD/Dose) & (2019-2030)

Figure 18. Biosimilar Drug Report Years Considered

Figure 19. Biosimilar Drug Sales Share by Manufacturers in 2023

Figure 20. Global Biosimilar Drug Revenue Share by Manufacturers in 2023

Figure 21. The Global 5 and 10 Largest Biosimilar Drug Players: Market Share by Revenue in 2023

Figure 22. Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 23. Global Biosimilar Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Biosimilar Drug Sales Market Share by Country (2019-2030)

Figure 25. North America Biosimilar Drug Revenue Market Share by Country (2019-2030)

Figure 26. U.S. Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Biosimilar Drug Sales Market Share by Country (2019-2030)

Figure 29. Europe Biosimilar Drug Revenue Market Share by Country (2019-2030)

Figure 30. Germany Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Biosimilar Drug Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Biosimilar Drug Revenue Market Share by Region (2019-2030)

Figure 37. China Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. China Taiwan Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Indonesia Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Thailand Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Malaysia Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Biosimilar Drug Sales Market Share by Country (2019-2030)

Figure 47. Latin America Biosimilar Drug Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Biosimilar Drug Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Biosimilar Drug Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. UAE Biosimilar Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Biosimilar Drug by Type (2019-2030)

Figure 57. Global Revenue Market Share of Biosimilar Drug by Type (2019-2030)

Figure 58. Global Biosimilar Drug Price (USD/Dose) by Type (2019-2030)

Figure 59. Global Sales Market Share of Biosimilar Drug by Application (2019-2030)

Figure 60. Global Revenue Market Share of Biosimilar Drug by Application (2019-2030)

Figure 61. Global Biosimilar Drug Price (USD/Dose) by Application (2019-2030)

Figure 62. Biosimilar Drug Value Chain

Figure 63. Biosimilar Drug Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions